Literature DB >> 6163720

Elicitation of natural killer cells in beige mice by infection with vesicular stomatitis virus.

K P McKinnon, A H Hale, M J Ruebush.   

Abstract

Vesicular stomatitis virus (VSV) infection of beige (bg/bg) mice induced levels of natural killer cytolytic activity comparable to that of uninfected normal bg/+ controls, but considerably less than natural killer activity in VSV-infected bg/+ mice. In contrast, VSV-infected bg/bg and bg/+ mice had essentially equivalent amounts of anti-VSV cytotoxic T-lymphocyte and antibody activity. VSV infection induced comparable levels of interferon in both bg/bg and bg/+ mice. Therefore, the decreased natural killer activity in bg/bg mice could not be attributed to an inability to produce interferon.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163720      PMCID: PMC350608          DOI: 10.1128/iai.32.1.204-210.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Association of disease susceptibility to major histocompatibility antigens.

Authors:  R M Zinkernagel
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

Review 2.  Mechanisms of activation of human natural killer cells against tumor and virus-infected cells.

Authors:  D Santoli; H Koprowski
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Vesicular stomatitis virus glycoprotein is necessary for H-2-restricted lysis of infected cells by cytotoxic T lymphocytes.

Authors:  A H Hale; O N Witte; D Baltimore; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

4.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

5.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

6.  The glycoprotein of vesicular stomatitis virus is the antigen that gives rise to and reacts with neutralizing antibody.

Authors:  J M Kelley; S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

7.  Unique lectin-binding characteristics of cytotoxic T lymphocytes allowing their distinction from natural killer cells and "K" cells.

Authors:  A Kimura; A Orn; G Holmquist; H Wigzell; B Ersson
Journal:  Eur J Immunol       Date:  1979-07       Impact factor: 5.532

Review 8.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

9.  Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles.

Authors:  M Stampfer; D Baltimore; A S Huang
Journal:  J Virol       Date:  1969-08       Impact factor: 5.103

10.  Absence of interference during high-multiplicity infection by clonally purified vesicular stomatitis virus.

Authors:  M Stampfer; D Baltimore; A S Huang
Journal:  J Virol       Date:  1971-03       Impact factor: 5.103

View more
  8 in total

1.  Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus.

Authors:  R O Jacoby; P N Bhatt; D G Brownstein
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 2.  Natural killer cells in resistance to virus-infected cells.

Authors:  B Rager-Zisman; B R Bloom
Journal:  Springer Semin Immunopathol       Date:  1982

3.  Investigation of porcine natural-killer cell activity with reference to African swine-fever virus infection.

Authors:  S G Norley; R C Wardley
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

4.  Resistance to infections in mice with defects in the activities of mononuclear phagocytes and natural killer cells: effects of immunomodulators in beige mice and 89Sr-treated mice.

Authors:  P S Morahan; P H Coleman; S S Morse; A Volkman
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

5.  In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.

Authors:  O Sorensen; R Dugre; D Percy; S Dales
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

6.  The cooperative effect of the satin and beige mutations in the suppression of NK and CTL activities in mice.

Authors:  R C McGarry; R Walker; J C Roder
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  Genetic resistance to murine cryptococcosis: the beige mutation (Chédiak-Higashi syndrome) in mice.

Authors:  G Marquis; S Montplaisir; M Pelletier; S Mousseau; P Auger
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

8.  Quantification of B16 melanoma cells in lungs using triplex Q-PCR--a new approach to evaluate melanoma cell metastasis and tumor control.

Authors:  Maria R Sorensen; Sara R Pedersen; Annika Lindkvist; Jan P Christensen; Allan R Thomsen
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.